HEADER HYDROLASE 21-AUG-12 4B7N TITLE H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R TITLE 2 NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS CAVEAT 4B7N NAG A 521 HAS WRONG CHIRALITY AT ATOM C1 CHIRALITY ERROR AT CAVEAT 2 4B7N C1 CENTER OF NAG A 521 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEURAMINIDASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: ZANAMIVIR LIGAND BOUND SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS SOURCE 3 (A/NETHERLANDS/2631/2010(H1N1)); SOURCE 4 ORGANISM_TAXID: 1027873; SOURCE 5 VARIANT: H1N1; SOURCE 6 EXPRESSION_SYSTEM: GALLUS GALLUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHICKEN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9031; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: RECOMBINANT INFLUENZA VIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHW2000; SOURCE 11 OTHER_DETAILS: PATIENT ISOLATE KEYWDS HYDROLASE, NEURAMINIDASE INHIBITOR, NAI, NAIS, OSELTAMIVIR, ANTIVIRAL KEYWDS 2 RESISTANCE, IMMUNOCOMPROMISED EXPDTA X-RAY DIFFRACTION AUTHOR E.VAN DER VRIES,S.G.VACHIERI,X.XIONG,J.LIU,P.J.COLLINS,P.A.WALKER, AUTHOR 2 L.F.HAIRE,A.J.HAY,M.SCHUTTEN,A.D.M.E.OSTERHAUS,S.R.MARTIN, AUTHOR 3 C.A.B.BOUCHER,J.J.SKEHEL,S.J.GAMBLIN REVDAT 6 06-NOV-24 4B7N 1 REMARK REVDAT 5 20-DEC-23 4B7N 1 HETSYN REVDAT 4 29-JUL-20 4B7N 1 CAVEAT COMPND REMARK HETNAM REVDAT 4 2 1 LINK SITE REVDAT 3 12-DEC-12 4B7N 1 REMARK LINK REVDAT 2 10-OCT-12 4B7N 1 JRNL REVDAT 1 03-OCT-12 4B7N 0 JRNL AUTH E.VAN DER VRIES,P.J.COLLINS,S.G.VACHIERI,X.XIONG,J.LIU, JRNL AUTH 2 P.A.WALKER,L.F.HAIRE,A.J.HAY,M.SCHUTTEN,A.D.M.E.OSTERHAUS, JRNL AUTH 3 S.R.MARTIN,C.A.B.BOUCHER,J.J.SKEHEL,S.J.GAMBLIN JRNL TITL H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R JRNL TITL 2 NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL JRNL TITL 3 ANALYSIS JRNL REF PLOS PATHOG. V. 8 2914 2012 JRNL REFN ISSN 1553-7366 JRNL PMID 23028314 JRNL DOI 10.1371/JOURNAL.PPAT.1002914 REMARK 2 REMARK 2 RESOLUTION. 2.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 83.62 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 11333 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 567 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.84 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.92 REMARK 3 REFLECTION IN BIN (WORKING SET) : 702 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.20 REMARK 3 BIN R VALUE (WORKING SET) : 0.2860 REMARK 3 BIN FREE R VALUE SET COUNT : 41 REMARK 3 BIN FREE R VALUE : 0.3160 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2989 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.10000 REMARK 3 B22 (A**2) : -0.10000 REMARK 3 B33 (A**2) : 0.19000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.344 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.239 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.419 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3179 ; 0.006 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4328 ; 1.037 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 385 ; 5.580 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 140 ;33.909 ;24.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 478 ;14.464 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ; 9.781 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 461 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2452 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4B7N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1290053813. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JAN-11 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11923 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.840 REMARK 200 RESOLUTION RANGE LOW (A) : 83.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.30 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.30 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3NSS REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG3350, 0.2M SODIUM FLUORIDE AND REMARK 280 0.1M BIS-TRIS PROPANE BUFFER (PH 6.5) REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 59.17500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 59.17500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 59.17500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 59.17500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 59.17500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.17500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 59.17500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.17500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 17920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45060 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -62.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 59.17500 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 59.17500 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 118.35000 REMARK 350 BIOMT2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 -1.000000 0.000000 59.17500 REMARK 350 BIOMT2 4 1.000000 0.000000 0.000000 -59.17500 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2013 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 PRO A 3 REMARK 465 ASN A 4 REMARK 465 GLN A 5 REMARK 465 LYS A 6 REMARK 465 ILE A 7 REMARK 465 ILE A 8 REMARK 465 THR A 9 REMARK 465 ILE A 10 REMARK 465 GLY A 11 REMARK 465 SER A 12 REMARK 465 VAL A 13 REMARK 465 CYS A 14 REMARK 465 MET A 15 REMARK 465 THR A 16 REMARK 465 ILE A 17 REMARK 465 GLY A 18 REMARK 465 MET A 19 REMARK 465 ALA A 20 REMARK 465 ASN A 21 REMARK 465 LEU A 22 REMARK 465 ILE A 23 REMARK 465 LEU A 24 REMARK 465 GLN A 25 REMARK 465 ILE A 26 REMARK 465 GLY A 27 REMARK 465 ASN A 28 REMARK 465 ILE A 29 REMARK 465 ILE A 30 REMARK 465 SER A 31 REMARK 465 ILE A 32 REMARK 465 TRP A 33 REMARK 465 ILE A 34 REMARK 465 SER A 35 REMARK 465 HIS A 36 REMARK 465 SER A 37 REMARK 465 ILE A 38 REMARK 465 GLN A 39 REMARK 465 LEU A 40 REMARK 465 GLY A 41 REMARK 465 ASN A 42 REMARK 465 GLN A 43 REMARK 465 ASN A 44 REMARK 465 GLN A 45 REMARK 465 ILE A 46 REMARK 465 GLU A 47 REMARK 465 THR A 48 REMARK 465 CYS A 49 REMARK 465 ASN A 50 REMARK 465 GLN A 51 REMARK 465 SER A 52 REMARK 465 VAL A 53 REMARK 465 ILE A 54 REMARK 465 THR A 55 REMARK 465 TYR A 56 REMARK 465 GLU A 57 REMARK 465 ASN A 58 REMARK 465 ASN A 59 REMARK 465 THR A 60 REMARK 465 TRP A 61 REMARK 465 VAL A 62 REMARK 465 ASN A 63 REMARK 465 GLN A 64 REMARK 465 THR A 65 REMARK 465 TYR A 66 REMARK 465 VAL A 67 REMARK 465 ASN A 68 REMARK 465 ILE A 69 REMARK 465 SER A 70 REMARK 465 ASN A 71 REMARK 465 THR A 72 REMARK 465 ASN A 73 REMARK 465 PHE A 74 REMARK 465 ALA A 75 REMARK 465 ALA A 76 REMARK 465 GLY A 77 REMARK 465 GLN A 78 REMARK 465 SER A 79 REMARK 465 VAL A 80 REMARK 465 VAL A 81 REMARK 465 SER A 82 REMARK 465 LYS A 469 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 235 N2 NAG A 521 1.44 REMARK 500 ND2 ASN A 88 C2 NAG A 501 1.47 REMARK 500 ND2 ASN A 235 C2 NAG A 521 1.84 REMARK 500 ND2 ASN A 88 N2 NAG A 501 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 167 94.25 -68.53 REMARK 500 ARG A 223 70.41 52.16 REMARK 500 THR A 226 -162.25 -128.60 REMARK 500 CYS A 292 -166.24 -120.66 REMARK 500 TRP A 296 -71.74 -78.20 REMARK 500 HIS A 297 43.95 -148.79 REMARK 500 LYS A 331 -154.77 -109.92 REMARK 500 ASN A 344 -168.23 64.16 REMARK 500 ASN A 385 54.38 -105.85 REMARK 500 ILE A 393 -51.00 -124.51 REMARK 500 SER A 400 -137.43 -123.55 REMARK 500 TRP A 457 79.23 -113.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2109 DISTANCE = 5.82 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 701 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 294 O REMARK 620 2 GLY A 298 O 81.4 REMARK 620 3 ASP A 324 OD2 94.5 87.4 REMARK 620 4 GLY A 342 O 92.6 86.0 169.5 REMARK 620 5 ASN A 344 O 93.6 163.7 108.5 78.6 REMARK 620 6 HOH A2081 O 162.5 97.7 102.9 69.9 82.4 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4B7J RELATED DB: PDB REMARK 900 H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R REMARK 900 NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS REMARK 900 RELATED ID: 4B7M RELATED DB: PDB REMARK 900 H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R REMARK 900 NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS REMARK 900 RELATED ID: 4B7Q RELATED DB: PDB REMARK 900 H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R REMARK 900 NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS REMARK 900 RELATED ID: 4B7R RELATED DB: PDB REMARK 900 H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R REMARK 900 NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS DBREF 4B7N A 1 469 UNP F8UU09 F8UU09_9INFA 1 469 SEQRES 1 A 469 MET ASN PRO ASN GLN LYS ILE ILE THR ILE GLY SER VAL SEQRES 2 A 469 CYS MET THR ILE GLY MET ALA ASN LEU ILE LEU GLN ILE SEQRES 3 A 469 GLY ASN ILE ILE SER ILE TRP ILE SER HIS SER ILE GLN SEQRES 4 A 469 LEU GLY ASN GLN ASN GLN ILE GLU THR CYS ASN GLN SER SEQRES 5 A 469 VAL ILE THR TYR GLU ASN ASN THR TRP VAL ASN GLN THR SEQRES 6 A 469 TYR VAL ASN ILE SER ASN THR ASN PHE ALA ALA GLY GLN SEQRES 7 A 469 SER VAL VAL SER VAL LYS LEU ALA GLY ASN SER SER LEU SEQRES 8 A 469 CYS PRO VAL SER GLY TRP ALA ILE TYR SER LYS ASP ASN SEQRES 9 A 469 SER ILE ARG ILE GLY SER LYS GLY ASP VAL PHE VAL ILE SEQRES 10 A 469 ARG GLU PRO PHE ILE SER CYS SER PRO LEU GLU CYS ARG SEQRES 11 A 469 THR PHE PHE LEU THR GLN GLY ALA LEU LEU ASN ASP LYS SEQRES 12 A 469 HIS SER ASN GLY THR ILE LYS ASP ARG SER PRO TYR ARG SEQRES 13 A 469 THR LEU MET SER CYS PRO ILE GLY GLU VAL PRO SER PRO SEQRES 14 A 469 TYR ASN SER ARG PHE GLU SER VAL ALA TRP SER ALA SER SEQRES 15 A 469 ALA CYS HIS ASP GLY ILE ASN TRP LEU THR ILE GLY ILE SEQRES 16 A 469 SER GLY PRO ASP ASN GLY ALA VAL ALA VAL LEU LYS TYR SEQRES 17 A 469 ASN GLY ILE ILE THR ASP THR ILE LYS SER TRP ARG ASN SEQRES 18 A 469 ASN ARG LEU ARG THR GLN GLU SER GLU CYS ALA CYS VAL SEQRES 19 A 469 ASN GLY SER CYS PHE THR VAL MET THR ASP GLY PRO SER SEQRES 20 A 469 ASP GLY GLN ALA SER TYR LYS ILE PHE ARG ILE GLU LYS SEQRES 21 A 469 GLY LYS ILE VAL LYS SER VAL GLU MET ASN ALA PRO ASN SEQRES 22 A 469 TYR HIS TYR GLU GLU CYS SER CYS TYR PRO ASP SER SER SEQRES 23 A 469 GLU ILE THR CYS VAL CYS ARG ASP ASN TRP HIS GLY SER SEQRES 24 A 469 ASN ARG PRO TRP VAL SER PHE ASN GLN ASN LEU GLU TYR SEQRES 25 A 469 GLN ILE GLY TYR ILE CYS SER GLY ILE PHE GLY ASP ASN SEQRES 26 A 469 PRO ARG PRO ASN ASP LYS THR GLY SER CYS GLY PRO VAL SEQRES 27 A 469 SER SER ASN GLY ALA ASN GLY VAL LYS GLY PHE SER PHE SEQRES 28 A 469 LYS TYR GLY ASN GLY VAL TRP ILE GLY ARG THR LYS SER SEQRES 29 A 469 ILE SER SER ARG ASN GLY PHE GLU MET ILE TRP ASP PRO SEQRES 30 A 469 ASN GLY TRP THR GLY THR ASP ASN ASP PHE SER ILE LYS SEQRES 31 A 469 GLN ASP ILE VAL GLY ILE ASN GLU TRP SER GLY TYR SER SEQRES 32 A 469 GLY SER PHE VAL GLN HIS PRO GLU LEU THR GLY LEU ASP SEQRES 33 A 469 CYS ILE ARG PRO CYS PHE TRP VAL GLU LEU ILE ARG GLY SEQRES 34 A 469 ARG PRO LYS GLU ASN THR ILE TRP THR SER GLY SER SER SEQRES 35 A 469 ILE SER PHE CYS GLY VAL ASN SER ASP THR VAL GLY TRP SEQRES 36 A 469 SER TRP PRO ASP GLY ALA GLU LEU PRO PHE THR ILE ASP SEQRES 37 A 469 LYS MODRES 4B7N ASN A 88 ASN GLYCOSYLATION SITE MODRES 4B7N ASN A 146 ASN GLYCOSYLATION SITE MODRES 4B7N ASN A 235 ASN GLYCOSYLATION SITE HET NAG A 501 14 HET NAG A 511 14 HET NAG A 521 14 HET ZMR A 601 23 HET CA A 701 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZMR ZANAMIVIR HETNAM CA CALCIUM ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN ZMR 4-GUANIDINO-2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC HETSYN 2 ZMR ACID; 4-GUANIDINO-NEU5AC2EN; MODIFIED SIALIC ACID FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 5 ZMR C12 H20 N4 O7 FORMUL 6 CA CA 2+ FORMUL 7 HOH *110(H2 O) HELIX 1 1 ASN A 104 SER A 110 1 7 HELIX 2 2 ASP A 142 ASN A 146 5 5 HELIX 3 3 HIS A 409 GLY A 414 1 6 SHEET 1 AA 4 GLY A 96 LYS A 102 0 SHEET 2 AA 4 THR A 438 VAL A 448 -1 O SER A 444 N TYR A 100 SHEET 3 AA 4 ARG A 419 GLY A 429 -1 O PRO A 420 N GLY A 447 SHEET 4 AA 4 SER A 403 GLN A 408 -1 O GLY A 404 N TRP A 423 SHEET 1 AB 4 PHE A 115 CYS A 124 0 SHEET 2 AB 4 CYS A 129 LEU A 139 -1 O ARG A 130 N SER A 123 SHEET 3 AB 4 THR A 157 PRO A 162 -1 O THR A 157 N THR A 135 SHEET 4 AB 4 ARG A 173 VAL A 177 -1 O ARG A 173 N SER A 160 SHEET 1 AC 4 SER A 180 HIS A 185 0 SHEET 2 AC 4 TRP A 190 SER A 196 -1 O LEU A 191 N CYS A 184 SHEET 3 AC 4 VAL A 203 TYR A 208 -1 O VAL A 203 N SER A 196 SHEET 4 AC 4 ILE A 211 LYS A 217 -1 O ILE A 211 N TYR A 208 SHEET 1 AD 4 ALA A 232 VAL A 234 0 SHEET 2 AD 4 SER A 237 ASP A 244 -1 O SER A 237 N VAL A 234 SHEET 3 AD 4 SER A 252 GLU A 259 -1 O SER A 252 N ASP A 244 SHEET 4 AD 4 LYS A 262 GLU A 268 -1 O LYS A 262 N GLU A 259 SHEET 1 AE 4 SER A 280 ASP A 284 0 SHEET 2 AE 4 GLU A 287 VAL A 291 -1 O GLU A 287 N ASP A 284 SHEET 3 AE 4 PRO A 302 PHE A 306 -1 O VAL A 304 N CYS A 290 SHEET 4 AE 4 TYR A 312 TYR A 316 -1 O GLN A 313 N SER A 305 SHEET 1 AF 4 PHE A 349 TYR A 353 0 SHEET 2 AF 4 GLY A 356 ARG A 361 -1 O GLY A 356 N TYR A 353 SHEET 3 AF 4 ASN A 369 ASP A 376 -1 O GLU A 372 N ARG A 361 SHEET 4 AF 4 ILE A 389 TRP A 399 -1 O ILE A 389 N TRP A 375 SSBOND 1 CYS A 92 CYS A 417 1555 1555 2.04 SSBOND 2 CYS A 124 CYS A 129 1555 1555 2.04 SSBOND 3 CYS A 184 CYS A 231 1555 1555 2.04 SSBOND 4 CYS A 233 CYS A 238 1555 1555 2.05 SSBOND 5 CYS A 279 CYS A 292 1555 1555 2.04 SSBOND 6 CYS A 281 CYS A 290 1555 1555 2.03 SSBOND 7 CYS A 318 CYS A 335 1555 1555 2.04 SSBOND 8 CYS A 421 CYS A 446 1555 1555 2.04 LINK ND2 ASN A 88 C1 NAG A 501 1555 1555 1.44 LINK ND2 ASN A 146 C1 NAG A 511 1555 1555 1.44 LINK ND2 ASN A 235 C1 NAG A 521 1555 1555 1.47 LINK O ASP A 294 CA CA A 701 1555 1555 2.28 LINK O GLY A 298 CA CA A 701 1555 1555 2.51 LINK OD2 ASP A 324 CA CA A 701 1555 1555 2.80 LINK O GLY A 342 CA CA A 701 1555 1555 2.82 LINK O ASN A 344 CA CA A 701 1555 1555 2.41 LINK CA CA A 701 O HOH A2081 1555 1555 2.40 CISPEP 1 ASN A 325 PRO A 326 0 6.56 CISPEP 2 ARG A 430 PRO A 431 0 4.29 CISPEP 3 LEU A 463 PRO A 464 0 2.11 CRYST1 118.350 118.350 68.380 90.00 90.00 90.00 P 4 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008450 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008450 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014624 0.00000